HDAC4 and ovarian cancer: Stronach et al. have described that ovarian cancer cells resistant to cisplatin have upregulated expression of both HDAC4 and STAT1 and that downregulation of HDAC4 leads to platinum sensitization, increased caspase activation and apoptosis.